139
Participants
Start Date
October 13, 2015
Primary Completion Date
June 30, 2021
Study Completion Date
June 30, 2021
Rituximab
Rituximab SC 1400 mg
Cyclophosphamide
Cyclophosphamide will be administered as per standard local practice.
Doxorubicin
Doxorubicin will be administered as per standard local practice.
Vincristine
Vincristine will be administered as per standard local practice.
Prednisone
Prednisone will be administered as per standard local practice.
Fludarabine
Fludarabine will be administered as per standard local practice.
Aziza Othmana Hospital; Clinical Haematology, Tunis
Hopital Militaire d'instruction de Tunis; Service d'hématologie, Tunis
CHU Hédi Chacker; Service d'hématologie, Sfax
CHU Farhat Hached; Service d'hématologie, Sousse
CHU Fattouma Bourguiba, Monastir; Service d'hématologie, Monastir
Hôpital d'enfants de Rabat - Service d'hémato-oncologie pédiatrique, Rabat
Centre hospitalo-univerisitaire de Tizi Ouzou - Nedir Mohamed;Service d'hématologie, Tizi Ouzou
CHU 20 Aout Service D'Onco-Hematologie Pediatrique, Casablanca
Clinique AlMadina; Service hematologie, Casablanca
Hôpital Dorban CHU Annaba, Service d'Hématologie, Annaba
EHU Oran, Service d'Hématologie et de Thérapie Cellulaire, Oran
Centre Hospitalier Uni Ire de Marrakech; Oncologie-Hématologie, Marrakesh
EHS CAC Hospital FRANTZ FANON ZABANA BLIDA; Hematology ward, Blida
Hoffmann-La Roche
INDUSTRY